132 related articles for article (PubMed ID: 21058495)
41. [Experimental vaccines for sexually transmitted infections].
Jovanović M; Karadaglić D; Golusin Z; Brkić S; Poljacki M
Med Pregl; 2009; 62(1-2):42-8. PubMed ID: 19514600
[TBL] [Abstract][Full Text] [Related]
42. A prophylactic quadrivalent vaccine for the prevention of infection and disease related to HPV-6, -11, -16 and -18.
Goldstone SE; Vuocolo S
Expert Rev Vaccines; 2012 Apr; 11(4):395-406. PubMed ID: 22551023
[TBL] [Abstract][Full Text] [Related]
43. Male human papillomavirus vaccine acceptance is enhanced by a brief intervention that emphasizes both male-specific vaccine benefits and altruistic motives.
Bonafide KE; Vanable PA
Sex Transm Dis; 2015 Feb; 42(2):76-80. PubMed ID: 25585065
[TBL] [Abstract][Full Text] [Related]
44. Human papillomavirus vaccine acceptability among young adult men.
Gerend MA; Barley J
Sex Transm Dis; 2009 Jan; 36(1):58-62. PubMed ID: 18830138
[TBL] [Abstract][Full Text] [Related]
45. [Human papillomavirus vaccination. Consensus Conference in pediatric age].
Bartolozzi G; Bona G; Ciofi M; De Martino M; Di Pietro P; Duse M; Esposito S; Gasparini R; Mariani L; Marostica G; Paravati F; Plebani A; Principi N; Zuccotti GV; Tovo PA
Minerva Pediatr; 2007 Jun; 59(3):165-82. PubMed ID: 17519861
[TBL] [Abstract][Full Text] [Related]
46. Focus on research: weighing the benefits and costs of HPV vaccination of young men.
Kim JJ
N Engl J Med; 2011 Feb; 364(5):393-5. PubMed ID: 21288093
[No Abstract] [Full Text] [Related]
47. Human papillomavirus (HPV) vaccine acceptance and perceived effectiveness, and HPV infection concern among young New Zealand university students.
Chelimo C; Wouldes TA; Cameron LD
Sex Health; 2010 Sep; 7(3):394-6. PubMed ID: 20719233
[TBL] [Abstract][Full Text] [Related]
48. Epidemiology and prevention of Human Papillomavirus.
Manini I; Montomoli E
Ann Ig; 2018; 30(4 Supple 1):28-32. PubMed ID: 30062377
[TBL] [Abstract][Full Text] [Related]
49. Marketing and the HPV vaccine.
Betensky M
JAMA; 2009 Dec; 302(24):2660-1; author reply 2661. PubMed ID: 20040550
[No Abstract] [Full Text] [Related]
50. Interim statement on HPV immunization.
Davis DB; Lalonde AB
J Obstet Gynaecol Can; 2007 Jan; 29(1):61, 62. PubMed ID: 17346478
[No Abstract] [Full Text] [Related]
51. Human papillomavirus disease in adolescents: management and prevention.
Widdice LE
Adolesc Med State Art Rev; 2012 Apr; 23(1):192-206, xii-xiii. PubMed ID: 22764563
[TBL] [Abstract][Full Text] [Related]
52. Is uterine cervical cancer a potentially preventable sexually transmitted disease?
Mgone CS
P N G Med J; 1998 Jun; 41(2):47-50. PubMed ID: 10934543
[No Abstract] [Full Text] [Related]
53. Human papillomavirus vaccine.
Miller NB; Raychaudhuri G; Toerner JG
N Engl J Med; 2007 Sep; 357(11):1154-5; author reply 1155-6. PubMed ID: 17855679
[No Abstract] [Full Text] [Related]
54. Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial.
Muñoz N; Manalastas R; Pitisuttithum P; Tresukosol D; Monsonego J; Ault K; Clavel C; Luna J; Myers E; Hood S; Bautista O; Bryan J; Taddeo FJ; Esser MT; Vuocolo S; Haupt RM; Barr E; Saah A
Lancet; 2009 Jun; 373(9679):1949-57. PubMed ID: 19493565
[TBL] [Abstract][Full Text] [Related]
55. [Human papillomavirus nonavalent vaccine. Update 2017].
Bosch FX; Moreno D; Redondo E; Torné A
Semergen; 2017; 43(4):265-276. PubMed ID: 28549940
[TBL] [Abstract][Full Text] [Related]
56. Role of the nurse immuniser in implementing and maintaining the National Human Papillomavirus 'Cervical Cancer' Vaccine rollout through a school-based program in Victoria.
Kent H; Heffernan ME; Silvers J; Moore E; Garland SM
Sex Health; 2010 Sep; 7(3):391-3. PubMed ID: 20719232
[TBL] [Abstract][Full Text] [Related]
57. [Protection against uterine cervical cancer by HPV vaccines].
Inoue M
Uirusu; 2008 Dec; 58(2):155-63. PubMed ID: 19374193
[TBL] [Abstract][Full Text] [Related]
58. Planning for the HPV vaccine and its impact on cervical cancer prevention.
Bailey J; Cymet TC
Compr Ther; 2006; 32(2):102-5. PubMed ID: 16845153
[TBL] [Abstract][Full Text] [Related]
59. Challenges to accepting a human papilloma virus (HPV) vaccine: a qualitative study of Australian women.
Rosenthal D; Dyson S; Pitts M; Garland S
Women Health; 2007; 45(2):59-73. PubMed ID: 18019286
[TBL] [Abstract][Full Text] [Related]
60. Studies Find Single Dose of HPV Vaccines May Be Effective.
Larkin HD
JAMA; 2022 Nov; 328(19):1896. PubMed ID: 36378200
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
